Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01675154 |
|---|---|
| Brief Title: | Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia |
| First Submitted : | August 27, 2012 |
| First Submitted that Met QC Criteria : | August 28, 2012 |
| First Posted : | August 29, 2012 (Estimate) |
| Results First Submitted : | May 21, 2021 |
| Results First Submitted that Met QC Criteria : | July 26, 2021 |
| Results First Posted : | August 19, 2021 |
| Last Update Submitted that Met QC Criteria : | July 26, 2021 |
| Last Update Posted : | August 19, 2021 |